IPO

20 stories about IPO
בורסה בורסת תל אביב

Israeli Capital Markets Will Experience a Renaissance in 2018

31.12.17|Steven Schoenfeld
2017 saw the largest-ever acquisition of an Israeli technology company (Mobileye) and biotech company (NeuroDerm), charting a positive course for Israeli capital markets in 2018
254475_0_0_640_320_0_xx-large

The Year’s Seven Key Trends in Israeli Mergers and Acquisitions

29.12.17|Micki Shapira
Even without counting the Mobileye deal, 2017 was another strong year for M&A in Israel
תל אביב מבט על מ למעלה

CTech’s Daily Israeli Tech News Roundup

28.12.17|CTech
Israeli startups are in for fierce competition over talent in 2018. Globalization jumpstarts Israeli tech deals. Another strong year for IPOs on the Tel Aviv Stock Exchange
בורסה בורסת תל אביב

Another Strong Year for IPOs on the Tel Aviv Stock Exchange

28.12.17|Oren Freund
Celltick Technologies Ltd. joins Uzi manufacturer SK Group among the companies that have already made preparations for a 2018 stock market listing in Israel
יאיר שניר אחראי מיזוגים ורכישות

Globalization Jumpstarts Israeli Tech Deals

28.12.17|Meir Orbach
Companies from China, India, Japan and Europe contributed to the 110% increase in the total value of mergers, acquisitions and IPOs for Israel-based tech companies in 2017
ירון ויצנבליט PWC הייטק

After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%

27.12.17|Amarelle Wenkert
U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
עסקים ב קבלה לחיצת ידיים

Why Should Anyone Want to Buy You?

10.12.17|Zachi Zach
When you are running a startup and dreaming on making an exit, it is a good idea to think about what big companies want
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Japanese Technology Holding Company IRI Wants to Raise $30 Million in Tel Aviv IPO

03.12.17|Dror Reich
Tokyo-headquartered Internet Research Institute registered in Israel in August
תרופות  טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
בניין הבורסה של פרנקפורט

Frankfurt Stock Exchange Eyes Israel-Based Startups

09.11.17|Meir Orbach
The exchange's small and medium-sized enterprises segment sent representatives to Israel in search of startups that want a European IPO
רכבת ישראל תחנת חדרה

Train Safety Company Rail Vision Considers Nasdaq IPO

09.11.17|Golan Hazani
The company announced it is examining registration on Nasdaq, confirming an earlier Calcalist report
כנס מכון אהרון שלמה דברת

Venture Capitalist Sees a Window of Opportunity for Tech IPO Hopefuls

02.11.17|Meir Orbach
Israeli tech is emerging from an extended IPO and M&A slowdown says Viola Ventures founding partner Shlomo Dovrat
קטרינה לייק סטיטצ' פיקס

How Much is Stitch Fix Worth?

02.11.17|Assaf Gilad
A case study valuating pre-IPO companies
רון יקותיאל מייסד מנכל קולטורה הוועידה המוטסת סן פרנסיסקו

Video Company Kaltura on Path for U.S. IPO

01.11.17|Golan Hazani
Kaltura raised $50 million in 2016 from Goldman Sachs at an undisclosed valuation. In May a veteran chief financial officer who led past U.S. IPO joined the company
מנכ"ל פורסקאוט מייקל דסיזאר

Private Investment Terms Dampen Forescout’s Successful IPO

29.10.17|Lilach Baumer
On Friday, Forescout raised $116 million on its Nasdaq debut, selling 5.3 million shares at $22 per share
קטרינה לייק סטיטצ' פיקס

Five Interesting Points from Stitch Fix IPO Prospectus

23.10.17|Daniel Shinar
Daniel Shinar finds hidden gems in the prospectus of the online fashion retailer
מנכ"ל פורסקאוט מייקל דסיזאר

ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO

19.10.17|Dror Reich
The information security company aims to raise $96-$105.6 million in a Nasdaq IPO
אמיר וייסברג

Drug Conduction Company Prepares for Nasdaq IPO

08.10.17|Golan Hazani
Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site
מנכ"ל פורסקאוט מייקל דסיזאר

Forescout Files For $100 Million Nasdaq IPO

04.10.17|Dror Reich
Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan
סנאפצ'ט snapchat

Snap Partners With Advertising Company to Boost Revenue

03.10.17|Dror Reich and Amarelle Wenkert
The social platform partners with ad-tech company Perion’s creative ad division in attempt to boost ad revenue
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1